• Citer

Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial.

par Procter, Marion;Suter, Thomas;de Azambuja, Evandro ;Dafni, U;van Dooren, Veerle;Muehlbauer, Susanne;Climent, Miguel Angel;Rechberger, Ernst;Liu, Walter Tsang-Wu;Toi, Masakazu;Coombes, Raoul Charles;Dodwell, David;Pagani, Olivia;Madrid, Jorge;Hall, Marcia;Chen, Shin-Cheh;Focan, Christian;Muscholl, Michael;van Veldhuisen, Dirk J;Piccart-Gebhart, Martine
Référence Journal of clinical oncology, 28, 21, page (3422-3428)
Publication Publié, 2010-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial.
Auteur:	Procter, Marion; Suter, Thomas; de Azambuja, Evandro; Dafni, U; van Dooren, Veerle; Muehlbauer, Susanne; Climent, Miguel Angel; Rechberger, Ernst; Liu, Walter Tsang-Wu; Toi, Masakazu; Coombes, Raoul Charles; Dodwell, David; Pagani, Olivia; Madrid, Jorge; Hall, Marcia; Chen, Shin-Cheh; Focan, Christian; Muscholl, Michael; van Veldhuisen, Dirk J; Piccart-Gebhart, Martine
Informations sur la publication:	Journal of clinical oncology, 28, 21, page (3422-3428)
Statut de publication:	Publié, 2010-07
Sujet CREF:	Cancérologie
MeSH keywords:	Antibodies, Monoclonal -- adverse effects
	Antibodies, Monoclonal, Humanized
	Antineoplastic Agents -- adverse effects
	Breast Neoplasms -- drug therapy
	Female
	Heart Failure -- chemically induced
	Humans
	Receptor, erbB-2 -- analysis
	Ventricular Function, Left -- drug effects
Note générale:	Clinical Trial, Phase III
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2009.26.0463
	info:pii/JCO.2009.26.0463
	info:pmid/20530280